Endotoxemia clinical trials at UCSF
1 research study open to eligible people
Endotoxemia happens when toxins enter the bloodstream, causing inflammation. UCSF is studying a treatment using Polymyxin B Hemoperfusion to help people with septic shock. This study compares the new treatment with standard care to see if it works better.
Showing trials for
Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study
open to eligible people ages 18 years and up
Prospective, multicenter, randomized, open-label study of standard of care plus the PMX cartridge versus standard of care alone in patients with endotoxemic septic shock
San Francisco, California and other locations
Last updated: